PRODAN-Conjugated DNA
A R T I C L E S
(dd, 1H, J ) 2.2, 9.0 Hz), 6.92 (s, 1H), 5.57 (s, 1H), 3.06 (s, 6H), 2.71
(d, 1H, J ) 2.2 Hz), 2.25 (brs, 1H); 13C NMR (CDCl3, 100 MHz) δ
149.0, 134.9, 133.5, 129.0, 126.9, 126.3, 125.3, 124.9, 116.7, 106.3,
83.9, 74.6, 64.7, 40.8; FABMS (NBA/CHCl3) m/z 225 (M+), HRMS
calcd for C15H15ON (M+) 225.1154, found 225.1150.
1H NMR (CDCl3, 400 MHz) δ 8.33 (s, 1H), 8.16 (brs, 1H), 7.90 (dd,
1H, J ) 1.7, 8.7 Hz), 7.78 (d, 1H, J ) 9.2 Hz), 7.63-7.59 (m, 2H),
7.16 (dd, 1H, J ) 2.5, 9.1 Hz), 6.86 (d, 1H, J ) 2.2 Hz), 6.31 (dd, 1H,
J ) 5.9, 7.7 Hz), 4.42 (dt, 1H, J ) 2.7, 5.7 Hz), 3.94 (q, 1H, J ) 3.0
Hz), 3.84 (dd, 1H, J ) 3.6, 11.3 Hz), 3.78 (dd, 1H, J ) 3.3, 11.2 Hz),
3.41-3.24 (m, 2H), 3.10 (s, 6H), 2.79 (t, 2H, J ) 7.3 Hz), 2.23 (ddd,
1H, J ) 2.7, 5.8, 13.1 Hz), 2.02 (ddd, 1H, J ) 5.9, 7.7, 13.4 Hz),
0.92-0.90 (m, 18H), 0.11-0.07 (m, 12H); 13C NMR (CDCl3, 100
MHz) δ 198.3, 163.2, 150.2, 150.0, 137.6, 137.2, 130.7, 130.3, 130.0,
126.1, 125.1, 124.4, 116.3, 113.8, 105.3, 87.8, 84.9, 72.3, 63.1, 40.9,
40.4, 36.9, 25.9, 25.7, 22.7, 18.4, 18.0, -4.7, -4.8, -5.3, -5.4;
FABMS (NBA/CHCl3) m/z 682 ([M + H]+), HRMS calcd for
C36H56O6N3Si2 ([M + H]+) 682.3708, found 682.3704.
5-PRODAN-2′-deoxyuridine (5). To a solution of 4 (343 mg, 0.50
mmol) in THF (5 mL) was added tetrabutylammonium fluoride (1 M
solution in THF, 1.1 mL, 1.1 mmol). The mixture was stirred at room
temperature for 12 h. The resulting mixture was evaporated and purified
by silica gel column chromatography (chloroform-methanol ) 20:1)
to yield 5 (186 mg, 0.41 mmol, 82%) as a lemon yellow solid: 1H
NMR (DMSO-d6, 400 MHz) δ 11.4 (brs, 1H), 8.46 (s, 1H), 7.89 (d,
1H, J ) 9.2 Hz), 7.82 (dd, 1H, J ) 1.7, 8.7 Hz), 7.79 (s, 1H), 7.67 (d,
1H, J ) 8.8 Hz), 7.27 (dd, 1H, J ) 2.6, 9.2 Hz), 6.94 (d, 1H, J ) 2.4
Hz), 6.17 (t, 1H, J ) 6.9 Hz), 5.27 (brs, 1H), 5.09 (brs, 1H), 4.24 (m,
1H), 3.76 (q, 1H, J ) 3.5 Hz), 3.61-3.53 (m, 2H), 3.27-3.22 (m,
2H), 3.05 (s, 6H), 2.57 (t, 2H, J ) 7.6 Hz), 2.14-2.03 (m, 2H); 13C
NMR (DMSO-d6, 100 MHz) δ 198.2, 163.4, 150.3, 150.1, 137.2, 136.7,
130.6, 129.9, 129.6, 125.9, 124.5, 123.8, 116.4, 112.7, 104.7, 87.3,
83.9, 70.3, 61.2, 39.9, 39.4, 36.6, 21.8; FABMS (NBA/DMSO) m/z
454 ([M + H]+), HRMS calcd for C24H28O6N3 ([M + H]+) 454.1978,
found 454.1978.
5-[3-(6-Dimethylaminonaphthalen-2-yl)-3-hydroxy-1-propyn-1-
yl]-3′O,5′O-bis(tert-butyldimethylsilyl)-2′-deoxyuridine (3). To a
solution of 5-iodo-3′ O,5′O-bis(tert-butyldimethylsilyl)-2′-deoxyuridine
(2.9 g, 5.0 mmol), 2 (915 mg, 4.1 mmol), and triethylamine (1.7 mL,
12 mmol) in DMF (20 mL) were added tetrakis(triphenylphosphine)-
palladium(0) (950 mg, 0.82 mmol) and copper(I) iodide (310 mg, 1.6
mmol) under nitrogen. The mixture was stirred at room temperature
for 5 h. The resulting mixture was concentrated in Vacuo and diluted
with ethyl acetate. This solution was washed with 5% (w/v) EDTA
solution and 5% (w/v) sodium bisulfite solution, dried over Na2SO4,
filtered, and evaporated. The crude product was purified by silica gel
column chromatography (toluene-ethyl acetate ) 4:1) to yield 3 (3.2
g, 4.65 mmol, 93%) as a yellow solid: 1H NMR (CDCl3, 400 MHz) δ
8.59 (brs, 1H), 7.98 (d, 1H, J ) 3.3 Hz), 7.88 (s, 1H), 7.71 (d, 1H, J
) 9.0 Hz), 7.64 (d, 1H, J ) 9.6 Hz), 7.56 (dd, 1H, J ) 1.6, 8.5 Hz),
7.15 (dd, 1H, J ) 2.5, 9.1 Hz), 6.90 (d, 1H, J ) 2.0 Hz), 6.27 (dd, 1H,
J ) 5.8, 7.6 Hz), 5.73 (s, 1H), 4.39-4.37 (m, 1H), 3.97-3.96 (m,
1H), 3.85 (ddd, 1H, J ) 2.6, 5.4, 11.4 Hz), 3.74-3.71 (m, 1H), 3.04
(s, 6H), 2.69 (brs, 1H), 2.30 (ddd, 1H, J ) 2.5, 5.8, 13.1 Hz), 2.04-
1.96 (m, 1H), 0.89-0.83 (m, 18H), 0.08-0.02 (m, 12H); 13C NMR
(CDCl3, 100 MHz) δ 161.2, 149.0, 142.5, 134.9, 133.7, 129.1, 126.8,
126.43, 126.42, 125.52, 125.46, 125.12, 125.07, 116.6, 106.3, 99.6,
94.2, 88.4, 85.91, 85.88, 77.6, 77.5, 72.4, 65.3, 63.0, 42.0, 40.8, 25.9,
25.7, 18.3, 18.0, -4.8, -4.7, -5.4, -5.6; FABMS (NBA/CHCl3) m/z
679 (M+), HRMS calcd for C36H53O6N3Si2 (M+) 679.3473, found
679.3475.
5-PRODAN-5′O-(4,4′-dimethoxytrityl)-2′-deoxyuridine 3′O-(2-
cyanoethyl)-N,N-diisopropylphosphoramidite (6). To a solution of
5 (166 mg, 0.40 mmol) in pyridine (5 mL) was added 4,4′-dimethoxy-
trityl chloride (174 mg, 0.51 mmol). The mixture was stirred at room
temperature for 4 h. The resulting mixture was evaporated and purified
by silica gel column chromatography (ethyl acetate) to yield the
tritylated product (278 mg, 0.37 mmol, 93%) as a lemon yellow solid:
1H NMR (DMSO-d6, 400 MHz) δ 11.39 (brs, 1H), 8.31 (s, 1H), 7.83
(d, 1H, J ) 9.2 Hz), 7.71 (dd, 1H, J ) 1.6, 8.6 Hz), 7.63 (d, 1H, J )
8.8 Hz), 7.53 (s, 1H), 7.36 (d, 2H, J ) 7.5 Hz), 7.27-7.21 (m, 7H),
7.12 (t, 1H, J ) 7.3 Hz), 6.93 (d, 1H, J ) 2.4 Hz), 6.82 (d, 4H, J )
8.6 Hz), 6.22 (t, 1H, J ) 6.8 Hz), 5.30 (d, 1H, J ) 4.2 Hz), 4.32-4.27
(m, 1H), 3.88 (q, 1H, J ) 3.8 Hz), 3.64 (s, 6H), 3.20 (d, 2H, J ) 4.0
Hz), 3.05 (s, 6H), 3.03 (t, 2H, J ) 7.7 Hz), 2.34-2.16 (m, 4H); 13C
NMR (DMSO-d6, 100 MHz) δ 197.7, 170.2, 163.2, 158.1, 158.0, 150.2,
150.1, 144.6, 137.1, 136.4, 135.4, 135.3, 130.5, 129.7, 129.5, 127.8,
127.6, 126.6, 125.8, 124.5, 123.7, 116.3, 113.1, 113.0, 104.7, 85.7,
85.5, 83.9, 70.5, 63.8, 54.9, 39.9, 39.3, 36.8, 21.6; FABMS (NBA/
DMSO) m/z 755 ([M + H]+), HRMS calcd for C45H45O8N3 ([M +
H]+) 755.3207, found 755.3212.
5-PRODAN-3′O,5′O-bis(tert-butyldimethylsilyl)-2′-deoxyuri-
dine (4). A mixture of 3 (673 mg, 0.99 mmol) and 10% Pd/C (180
mg) in methanol (10 mL) was stirred under hydrogen atmosphere at
room temperature for 9 h. The mixture was filtered through Celite,
washed with methanol, and evaporated under reduced pressure. The
crude product was purified by silica gel chromatography (hexane-
ethyl acetate ) 3:1) to yield the corresponding reduction product
(diastereomeric mixture, 488 mg, 0.71 mmol, 72%) as a yellow solid:
1H NMR (CDCl3, 400 MHz) δ 8.41 and 8.40 (s × 2, total 1H), 7.67
(d, 1H, J ) 9.0 Hz), 7.63 (s, 1H), 7.62 (d, 1H, J ) 8.6 Hz), 7.431 and
7.428 (s × 2, total 1H), 7.37 and 7.34 (t × 2, total 1H, J ) 1.8 Hz),
7.16 and 7.14 (d × 2, total 1H, J ) 2.4 Hz), 6.904 and 6.898 (s × 2,
total 1H), 6.30 (dd, 1H, J ) 5.7, 8.1 Hz), 4.78-4.72 (m, 1H), 4.37 (dt,
1H, J ) 2.6, 8.2 Hz), 3.92 (q, 1H, J ) 2.5 Hz), 3.79 (ddd, 1H, J )
2.9, 4.4, 11.4 Hz), 3.72 (dt, 1H, J ) 3.0, 11.4 Hz), 3.03 (s, 6H), 2.84
and 2.75 (brs × 2, total 1H), 2.56-2.41 (m, 2H), 2.222 and 2.216
(quintet × 2, total 1H, J ) 2.6 Hz), 2.09-1.90 (m, 3H), 0.89 (s, 9H),
0.86 (d, 9H, J ) 4.8 Hz), 0.08-0.02 (m, 12H); 13C NMR (CDCl3, 100
MHz) δ 163.6, 163.5, 149.93, 149.89, 148.7, 137.84, 137.75, 136.21,
136.16, 134.5, 128.7, 126.6, 124.4, 124.3, 124.2, 116.7, 114.6, 106.5,
87.9, 84.99, 84.96, 73.4, 73.3, 72.41, 72.36, 63.1, 63.0, 41.2, 40.9, 38.39,
38.36, 25.90, 25.88, 25.7, 23.9, 23.8, 18.4, 18.0, -4.5, -4.8, -5.40,
-5.43, -5.5; FABMS (NBA/CHCl3) m/z 681 (M+), HRMS calcd for
C36H55O6N3Si2 (M+) 681.3629, found 681.3632.
To a solution of the tritylated compound (30.2 mg, 40.0 µmol) and
tetrazole (3.08 mg, 43.7 µmol) in anhydrous acetonitrile (400 µL) was
added 2-cyanoethyl tetraisopropylphosphorodiamidite (13.1 µL, 40.0
µmol) under nitrogen. The mixture was stirred at room temperature
for 30 min. The mixture was filtered and used with no further
purification.
To a solution of the previous reaction product (104 mg, 0.15 mmol)
and molecular sieves (4 Å, 100 mg) in dichloromethane (4 mL) were
added 4-methylmorpholine N-oxide (26.4 mg, 0.23 mmol) and tetra-
propylammonium perruthenate (11 mg, 0.03 mmol) at 0 °C, and the
mixture was stirred at room temperature for 1 h. After dilution with
diethyl ether (10 mL), Florisil (60-100 mesh, 100 mg) was added to
the solution and the resulting mixture was stirred at room temperature
for 15 min. The mixture was filtered through Celite, washed with diethyl
ether, and evaporated under reduced pressure. The crude product was
purified by silica gel column chromatography (hexane-ethyl acetate
) 4:1) to yield 4 (88 mg, 0.13 mmol, 85%) as a lemon yellow solid:
ODN Synthesis and Characterization. ODNs were synthesized by
a conventional phosphoramidite method by using an Applied Bio-
systems 392 DNA/RNA synthesizer. Commercially available phos-
phoramidites were used for dA, dG, dC, and dT. The crude mixture
after phosphoramidite synthesis was used for PDNX. Synthesized ODNs
were purified by reversed phase HPLC on a 5-ODS-H column (10 mm
× 150 mm, elution with a solvent mixture of 0.1 M triethylamine acetate
(TEAA), pH 7.0, linear gradient over 30 min from 5% to 30%
acetonitrile at a flow rate of 3.0 mL/min). ODNs containing modified
nucleotides were fully digested with calf intestine alkaline phosphatase
9
J. AM. CHEM. SOC. VOL. 129, NO. 15, 2007 4783